Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma

Journal of Clinical Oncology

Volumn 14, Issue 2, 1996, Pages 565-571

  Travis, L B ^a   Weeks, J ^a   Curtis, R E ^a   Chaffey, J T ^a   Stovall, M ^a   Banks, P M ^a   Boice Jr , J D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0030061685     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.2.565     Document Type: Article

References (46)

1. Johnson RE: Total body irradiation (TBI) as primary therapy for advanced lymphosarcoma. Cancer 35:242-246, 1975
2. Hoppe RT, Kushlan P, Kaplan HS, et al: The treatment of advanced stage favorable histology non-Hodgkin's lymphoma: A preliminary report of a randomized trial comparing single agent chemotherapy, combination chemotherapy, and whole body irradiation. Blood 58:592-598, 1981
3. Darrington DL, Vose JM, Anderson JR, et al: Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. J Clin Oncol 12:2527-2534, 1994
4. Jacobs P, King HS: A randomized prospective comparison of chemotherapy to total body irradiation as initial treatment for the indolent lymphoproliferative diseases. Blood 69:1642-1646, 1987
5. Lybeert MLM, Meerwaldt JH, Deneve W: Long-term results of low dose total body irradiation for advanced non-Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 13:1167-1172, 1987
6. Meerwaldt JH, Carde P, Burgers JMV, et al: Low-dose total body irradiation versus combination chemotherapy for lymphomas with follicular growth pattern. Int J Radiat Oncol Biol Phys 21:1167-1172, 1991
7. Roncadin M, Arcicasa M, Zagonel V, et al: Total body irradiation and prednimustine in chronic lymphocytic leukemia and low grade non-Hodgkin's lymphomas. Cancer 74:978-984, 1994
8. Robins HI: Combined modality clinical trials for favorable B-cell neoplasms: Lonidamine plus whole body hyperthermia and/or total body irradiation. Semin Oncol 18:23-27, 1991
9. Kardamakis D, Berry RJ: Low-dose total-body irradiation in the management of refractory rheumatoid arthritis. Br J Radiol 60:297-299, 1987
10. Durelli L, Ferrio MF, Urgesi A, et al: Total body irradiation for myasthenia gravis: A long-term follow-up. Neurology 43:2215-2221, 1993
11. Greene MH, Young RC, Merrill JM, et al: Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma. Cancer Res 43:1891-1898, 1983
12. Mendenhall NP, Noyes WD, Million RR: Total body irradiation for stage II-IV non-Hodgkin's lymphoma: Ten-year follow-up. J Clin Oncol 7:67-74, 1989
13. Johnson RE, Canellos GP, Young RC, et al: Chemotherapy (cyclophosphamide, vincristine, and prednisone) versus radiotherapy (total body irradiation) for stage III-IV poorly differentiated lymphocytic lymphoma. Cancer Treat Rep 62:321-325, 1978
14. Choi NC, Timothy AR, Kaufman SD, et al: Low dose fractionated whole-body irradiation in the treatment of advanced non-Hodgkin's lymphoma. Cancer 43:1636-1642, 1979
15. Thar TL, Million RR, Noyes WD: Total body irradiation in non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 5:171-176, 1979
16. Carabell SC, Chaffey JT, Rosenthal DS, et al: Results of total body irradiation in the treatment of advanced non-Hodgkin's lymphomas. Cancer 43:994-1000, 1979
17. Brereton HD, Young RC, Longo DL, et al: A comparison between combination chemotherapy and total body irradiation plus combination chemotherapy in non-Hodgkin's lymphoma. Cancer 43:2227-2231, 1979
18. Rees GJ, Bullimore JA, Lever JV, et al: Total body irradiation as a secondary therapy in non-Hodgkin's lymphoma. Clin Radiol 31:437-439, 1980
19. Dodds HJ, Barrett A, Rostom AY, et al: Total-body irradiation in advanced non-Hodgkin's lymphoma. Br J Radiol 54:878-881, 1981
20. Weick JK, Antunez A, Kraus TA, et al: The combined modality therapy of diffuse histology non-Hodgkin's lymphoma with cyclophosphamide, Adriamycin, vincristine, prednisone (CHOP) and total body irradiation. Int J Radiat Oncol Biol Phys 9:1205-1207, 1983
21. Tamura K, Okayama A, Koga K, et al: Total body irradiation as a primary treatment for adult T-cell leukemia. Jpn J Clin Oncol 13:313-324, 1983
22. Chaffey JT, Hellman S, Rosenthal DS, et al: Total body irradiation in the treatment of lymphocytic lymphoma. Cancer Treat Rep 61:1149-1152, 1977
23. Travis LB, Curtis RE, Stovall M, et al: Risk of leukemia following treatment for non-Hodgkin's lymphoma. J Natl Cancer Inst 86:1450-1457, 1994
24. Travis LB, Curtis RE, Glimelius B, et al: Second cancers among long-term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst 85:1932-1937, 1993
25. Bennett JM, Catovsky D, Daniel MT, et al: Proposals for the classification of the acute leukaemias. Br J Haematol 33:451-458, 1976
26. Bennett JM, Catovsky D, Daniel MT, et al: Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189-199, 1982
27. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 49:2112-2135, 1982
28. Stovall M, Smith SA, Rosenstein M: Tissue doses from radiotherapy of cancer of the uterine cervix. Med Phys 16:726-733, 1989
29. Kaplan HS, Meier P: Non-parametric estimations from incomplete observations. J Am Stat Assoc 53:457-481, 1958
30. Bagley CM Jr, Devita VT Jr, Berard CW, et al: Advanced lymphosarcoma: Intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone. Ann Intern Med 76:227-234, 1972
31. McKelvey EM, Gottlieb JA, Wilson HE, et al: Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer 38:1484-1493, 1976
32. Stein RS, Moran EM, Desser RK, et al: Combination chemotherapy of lymphomas other than Hodgkin's disease. Ann Intern Med 81:601-608, 1974
33. Schein PS, Devita VT Jr, Hubbard S, et al: Bleomycin, Adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma. Ann Intern Med 85:417-422, 1976
34. United Nations Scientific Committee on the Effects of Atomic Radiation: Sources and Effects of Ionizing Radiation, the UNSCEAR 1994 Report to the General Assembly, With Scientific Annexes. New York, NY, United Nations, 1994
35. Rubin P, Constine LS, Scarantino CW: The paradoxes in patterns and mechanism of bone marrow regeneration after irradiation: Total body irradiation. Radiother Oncol 213:227-233, 1984
36. Curtis RE, Boice JD Jr, Stovall M, et al: Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 326:1745-1751, 1992
37. Gomez GA, Aggarwall KK, Han T: Post-therapeutic acute malignant myeloproliferative syndrome and acute nonlymphocytic leukemia in non-Hodgkin's lymphomas: Correlation with intensity of treatment. Cancer 50:2285-2288, 1982
38. Pedersen-Bjergaard J, Ersbøll J, Sørensen HM, et al: Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Ann Intern Med 103:195-200, 1985.
39. Lavey RS, Eby NL, Prosnitz LR: Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas. Cancer 66:80-88, 1990
40. Lishner M, Slingerland J, Barr J, et al: Second malignant neoplasms in patients with non-Hodgkin's lymphoma. Hematol Oncol 9:169-179, 1991
41. MacDougall BK, Weinerman BH, Kemel S: Second malignancies in non-Hodgkin's lymphoma. Cancer 48:1299-1301, 1981
42. Miller JS, Arthur DC, Litz CE, et al: Myelodysplastic syndrome after autologous bone marrow transplantation: An additional late complication of creative cancer therapy. Blood 88:3780-3786, 1994
43. Stone RM, Neuberg D, Soiffer R, et al: Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol 12:2535-2542, 1994
44. Boice JD Jr, Storm HH, Curtis RE, et al: Introduction to the study of multiple primary cancers. Natl Cancer Inst Monogr 68:3-9, 1985
45. Homing SJ, Rosenberg SA: The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med 311:1471-1475, 1984
46. Tefferi A, Phyliky RL: A clinical update on chronic lymphocytic leukemia. II. Critical analysis of current chemotherapeutic modalities. Mayo Clin Proc 67:457-461, 1992